Andrew Hudders
Overview
Andrew Hudders brings a wealth of experience in the securities markets, company financing, mergers and acquisitions, and general corporate matters, providing an experienced perspective to guide clients through structuring and executing successful transactions and operations.
Andrew represents companies in all stages of growth, ranging from well-established to those in the venture capital stages of development. His counselling includes corporate formation; board, executive and governance requirements; executive compensation and employment-related matters; operational contracts; strategic alliances; and mergers and acquisitions. He also has significant experience in equity and debt transactions, venture capital and private equity investment, equity-based plans, and public finance. He also is actively involved in public company SEC and stock exchange compliance and reporting.
In securities transactions, Andrew regularly represents companies and placement agents/underwriters in public and private offerings in their dealing with the Financial Industry Regulatory Authority (FINRA), U.S. Securities and Exchange Commission (SEC), state securities, and exchange requirements. Clients appreciate his broad exposure to domestic and cross-border transactions in a range of market conditions. Typical transactions include private placements, IPOs, 415 transactions, PIPEs, secondary and resale offerings, and going-private transactions. He has extensive experience in Special Purpose Acquisition Company (SPAC) offerings, SPAC business combination transactions, and reverse merger transactions and related financings.
Andrew also advises and assists companies with their SEC reporting obligations, annual meeting requirements, corporate governance, and securities compliance Clients have included both domestic and non-United States companies and individuals.
Credentials
Education
- Cambridge University (LLM)
- Georgetown University Law Center (J.D.)
- London School of Economics and Political Science (M.S.)
- Connecticut College (B.A.)
Court Admissions
- U.S. District Court for the Eastern District of New York
- Represented a placement agent in private placements for a software company and emergence from bankruptcy.
- Represented underwriters in IPO and secondary offerings by NASDAQ and New York Stock Exchange listed issuers.
- Represented a placement agent in a 415-shelf takedown for NASDAQ listed electronics issuer.
- Represented a placement agent in a PIPE transaction for seasoned NASDAQ issuer.
- Represented a digital media company issuer in a series of preferred and secured note private placements.
- Represented a NASDAQ-listed alternative fuels issuer in a series of PIPE and strategic investmentsRepresented SPACs in acquisitions of companies located in the People’s Republic of China.
- Represented a SPAC in its acquisition of waste recycling located in North America.
- Represented the principals in a merger of private companies in the beauty care products industry.
- Represented public companies in a roll-up of digital media companies.
- Represented a reverse merger public company in acquisition of a bio-energy company and subsequent roll-up acquisitions in the U.S. and United Kingdom.
- Represented a Netherlands-based company in the acquisition of a U.S. public company and U.S. roll-up acquisitions of fresh vegetable and fruit drink companies.
- Represented the Canadian target of a U.S. acquisition company in the film, television, and other media production.
- Represented public companies in the sale of a controlling interest to investors.
- Represented a company in a roll-up of medical device companies, academic institutional medical licenses, and private and public financing.
- Represented a Scottish medical therapy development company in its U.S. IPO and listing on NASDAQ.
- .
- Represented a Chinese target in its acquisition by a shell company and related PIPE of common stock.
- Represented a SPAC foreign private issuer in its formation and initial public offering.
- Represented a placement agent in a private placement of preferred stock to U.S. institutional investors by Chinese-based issuer.
- Represented a bio-products issuer in its AIM listing and related Regulation S offering.
- Represented a U.S. issuer based in Western Canada in a series of Regulation S offerings for working capital.
- “Private Equity and Venture Capital Investment in China,” Columbia Business School, China Business Conference
- “China’s investment Landscape and Development of the China Capital Market,” Columbia Business School, China Business Conference
- “U.S. Capital Markets for Smaller Chinese Companies,” Harvard Business School, Asia Business Conference